Dr. Sharlaa Badal-Faesen

Sharlaa Badal-Faesen is a clinical researcher whose work centers on HIV, tuberculosis, and emerging infectious diseases, with a strong focus on vaccine science and women’s health. Affiliated with major international trial networks, including AIDS Clinical Trials Group collaborations, her research addresses pressing public health challenges in low- and middle-income settings, particularly across sub-Saharan Africa.

Her publications highlight leadership in large multicountry clinical trials evaluating COVID-19 vaccines in people living with HIV, including studies on hybrid immunity, heterologous boosting, and variant-adapted platforms. She has also contributed to pivotal work on tuberculosis treatment outcomes, standardized trial methodologies, and the interaction between systemic inflammation, anemia, and TB risk in advanced HIV.

Additional contributions span pharmacokinetic and pharmacogenetic investigations of antiretroviral and tuberculosis therapies, including their impact on hormonal contraception. Collectively, this body of work demonstrates expertise in clinical trial design, immunogenicity, drug–drug interactions, and implementation-focused research aimed at improving outcomes for vulnerable populations.